CAS 2376398-43-3

Butanamide, N-[6-cyano-4,7-difluoro-1-(1-methylcyclobutyl)-1H-benzimidazol-2-yl]-3,3-dimethyl-

Description:

Butanamide, N-[6-cyano-4,7-difluoro-1-(1-methylcyclobutyl)-1H-benzimidazol-2-yl]-3,3-dimethyl- is a synthetic organic compound characterized by its complex structure, which includes a benzimidazole core substituted with cyano and difluoro groups, as well as a cyclobutyl moiety. This compound is likely to exhibit properties typical of amides, such as moderate polarity due to the presence of the amide functional group, which can engage in hydrogen bonding. The presence of fluorine atoms may enhance its lipophilicity and influence its biological activity. Additionally, the cyano group can contribute to the compound's reactivity and potential applications in medicinal chemistry. The specific arrangement of substituents suggests that it may possess unique pharmacological properties, making it of interest in drug development. However, detailed studies would be necessary to fully elucidate its physical and chemical properties, including solubility, stability, and potential biological effects. As with many synthetic compounds, safety and handling precautions should be observed due to potential toxicity or reactivity.

Formula: C₁₉H₂₂F₂N₄O

Synonyms:

• Butanamide, N-[6-cyano-4,7-difluoro-1-(1-methylcyclobutyl)-1H-benzimidazol-2-yl]-3,3-dimethyl-

Kv7.2/Kv7.3 activator-1

CAS: 2376398-43-3

Kv7.2/Kv7.3 Activator-1 (compound 517) serves as a powerful activator of the Kv7.2/Kv7.3 channels, exhibiting an EC50 value of less than 1 µM. It holds potential for use in neurological disease research.

Formula: C₁₉H₂₂F₂N₄O

Color and Shape: Solid

Molecular weight: 360.40

Ref: TM-T89880